Short answer: increasingly, yes. Since December 2025 most Australian states and territories have started letting GPs diagnose ADHD and start stimulant medication, usually after completing approved training. As at November 2026, GP diagnosis is live in Queensland, New South Wales (for Endorsed Prescribers), Western Australia and South Australia, and is being introduced in Tasmania, Victoria and the ACT. The Northern Territory has announced no change. Because stimulants are Schedule 8 medicines, GPs who take on this work need to stay within their state’s rules, their training and their indemnity cover.
Last reviewed: November 2026. Written by Eric Lowenstein, Founder and CEO of Tego Insurance.
Key takeaways
- ADHD stimulants such as dexamfetamine, lisdexamfetamine and methylphenidate are Schedule 8 controlled medicines.
- Queensland has moved furthest, letting GPs initiate and continue stimulants without prior approval within set limits. Most other states require GPs to complete training and become accredited or endorsed.
- The rules that apply are those of the state or territory where the patient is, which matters for telehealth.
- The main medico-legal risks are inadequate assessment, missed comorbidities, prescribing outside your authority, poor documentation and diversion.
- Tell your medical indemnity insurer if ADHD diagnosis and prescribing becomes part of your practice.
Can GPs diagnose ADHD in each state and territory?
The table summarises published arrangements as at 19 November 2026. The rules are changing quickly, so always check your state or territory health department before prescribing.
| State or territory | Can GPs diagnose and start stimulants? | Key conditions |
|---|---|---|
| Queensland | Yes, since 1 December 2025 | GPs can initiate, adjust and continue stimulants without prior approval within authorised age groups, indications and maximum daily doses. Approval is needed outside those limits. Check QScript before prescribing. |
| New South Wales | Yes, for Endorsed Prescribers | About 1,700 trained GPs can continue prescribing for stable, previously diagnosed patients (since 1 September 2025). From late October 2026, around 300 Endorsed Prescribers who completed NSW Health training can diagnose and start treatment for patients aged 6 and over. Another training intake starts in November 2026. An NSW authority number must appear on prescriptions. |
| Western Australia | Yes, for accredited GPs | About 65 GPs have completed supervised training and can assess and prescribe for patients aged 10 and over. Other GPs follow existing co-prescribing rules. |
| South Australia | Yes, for accredited GPs, since February 2026 | About 100 trained GPs can assess and prescribe for patients aged 8 and over. Others use shared care, and ongoing prescribing beyond two months needs an authority from the Drugs of Dependence Unit. |
| Tasmania | Being introduced | About 50 trained GPs began ADHD assessments on 1 October 2026. Interstate prescribers must check TasScript and obtain authorisation. |
| Victoria | Not yet | About 150 GPs are training to diagnose and treat ADHD in people over 6, but cannot start until regulations change. Until then, GPs need a Schedule 8 treatment permit to continue treatment after a specialist diagnosis. |
| Australian Capital Territory | Partly | Trained GPs can manage ongoing prescribing for stable patients after notifying the Chief Health Officer. GP diagnosis is being introduced. Other practitioners need Chief Health Officer approval. |
| Northern Territory | No change announced | A specialist generally diagnoses and starts treatment. Prescribers need a patient-specific authorisation. |
Telehealth tip: the rules of the state or territory where the patient is located apply, not the rules where you are. Some approvals can only be held by local prescribers. Read our guide to telehealth legal risks for GPs.
Why does GP ADHD prescribing increase medico-legal risk?
More GPs managing ADHD is good for access. It also moves a complex diagnostic task, and a group of medicines with misuse potential, into general practice. Regulators are alert to high-volume prescribing of Schedule 8 medicines, and Ahpra has said it may look at practitioners with unusually high prescribing rates even without a complaint.
Complaints and claims in this area are likely to come from five sources.
1. Inadequate assessment
An ADHD diagnosis needs a thorough history, including childhood symptoms, collateral information where available, functional impairment across settings and validated rating tools. A diagnosis based on a brief consultation or an online questionnaire alone will be hard to defend.
2. Missed comorbidities and differential diagnoses
Anxiety, depression, bipolar disorder, trauma, sleep disorders, substance use and thyroid disease can mimic or sit alongside ADHD. Stimulants can worsen some conditions, and cardiovascular assessment matters before treatment starts.
3. Prescribing outside your authority
Each jurisdiction sets its own age limits, dose limits, training requirements and permit rules. Prescribing outside them can be a regulatory offence as well as a professional conduct issue. See our guide to prescribing Schedule 8 and controlled medications.
4. Monitoring and diversion
Check your state’s real-time prescription monitoring system before every prescription. Watch for early repeat requests, lost scripts and patients seeing multiple prescribers. Review blood pressure, heart rate, weight, sleep and mood regularly.
5. Documentation and consent
Record how you reached the diagnosis, the alternatives you considered, the consent discussion including risks and side effects, advice on driving, and your follow-up plan. Our article on informed consent sets out what good consent looks like.
A risk checklist for GPs taking on ADHD care
- Complete your state’s approved training and keep evidence of it.
- Work within the ages, doses and medicines your authority covers.
- Use a structured assessment process and validated rating scales.
- Seek collateral history and previous records where you can.
- Screen for mental health comorbidities, substance use and cardiovascular risk.
- Check real-time prescription monitoring every time.
- Obtain and document informed consent, including non-drug options.
- Set a review schedule and stick to it.
- Know when to refer. Complexity, diagnostic uncertainty and poor response are all reasons to involve a psychiatrist or paediatrician.
- Be cautious about business models built on high-volume, telehealth-only ADHD assessment.
Is ADHD prescribing covered by your medical indemnity insurance?
Medical indemnity cover is based on the practice you have described to your insurer. If diagnosing ADHD and starting stimulants is new to your scope of practice, tell your insurer so your cover reflects what you do. This matters most if ADHD care becomes a large part of your work or is delivered mainly by telehealth, as telehealth conditions can apply under indemnity policies. See medical indemnity for GPs.
Tego clients can call our 24/7 medico-legal advisers on 1300 834 683 with questions about prescribing obligations.
Frequently asked questions
Can a GP diagnose ADHD in adults in Australia?
In Queensland, New South Wales (Endorsed Prescribers), Western Australia and South Australia, yes, provided the GP meets that state’s requirements. Tasmania, Victoria and the ACT are introducing GP diagnosis. In the Northern Territory a specialist still makes the diagnosis.
Can any GP prescribe ADHD medication?
Any GP can usually continue prescribing under shared care or with the relevant permit after a specialist diagnosis. Starting treatment without a specialist is limited to GPs who meet their state’s requirements.
Are ADHD medications Schedule 8?
Yes. Stimulants including dexamfetamine, lisdexamfetamine and methylphenidate are Schedule 8 controlled medicines.
Can I prescribe ADHD medication by telehealth to a patient in another state?
Only if you meet the requirements of the state or territory where the patient is located. Some jurisdictions limit approvals to local prescribers.
Is there a Medicare item for ADHD assessment by a GP?
At the time of writing there is no specific Medicare item number for ADHD assessment. GPs use standard consultation items, and some states fund assessments directly.
What should I do if I receive a complaint about ADHD prescribing?
Contact your medical indemnity insurer before responding. Early advice makes a real difference.
If you have received a complaint, read our guide to responding to an HCCC or Ahpra complaint.
General information only. This article is not legal or clinical advice and does not take into account your circumstances. Laws differ between jurisdictions and change frequently. Insurance cover is subject to the terms, conditions and exclusions of the policy. Tego Insurance Pty Ltd (ABN 34 608 505 960, AFSL 482467) acts on behalf of certain underwriters at Lloyd’s.
Sources and further reading
- RACGP, ADHD reform: expanding GP-led diagnosis and management, state and territory announcements
- NSW Health, ADHD reforms and Endorsed Prescriber program
- Queensland Health, Medicines and Poisons (Medicines) Regulation 2021 and ADHD prescribing changes from 1 December 2025
- State and territory health department guidance for WA, SA, Tasmania, Victoria, the ACT and the NT
- Australasian ADHD Professionals Association, Australian Evidence-Based Clinical Practice Guideline for ADHD